Elucid
3 known investors
Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
Investors Β· 3
Frequently asked questions
- What does Elucid do?
- Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
- Who are Elucid's investors?
- Elucid's investors include Angel Physicians Fund, Aphelion Capital, BlueStone Venture Partners.